AV
ARCH Venture Partners IX, LLC bought $25M of LYEL stock
ARCH Venture Partners IX, LLC, 10% owner of Lyell Immunopharma, Inc. (LYEL), bought 2,321,262 shares of LYEL stock worth $25M, per an SEC Form 4 filed Nov 5, 2026.
The shares came through a private deal, not the open market.
The trade happened on Nov 4, 2026, 1 day before it was made public.
LYEL has moved -7.3% since the trade date, from $15.43 to $14.30 (Nov 13, 2026 close).
- Traded
- Nov 4, 2026
- Disclosed
- Nov 5, 2026
- Filing delay
- 1 day
- Price since
- -7.3%
- Role
- 10% owner
- Source
- SEC Form 4